Stockscreener 앱 받기
295.06
0.38%
-0.94
전일 마감가:
$296.00
열려 있는:
$289.13
하루 거래량:
210.11K
Relative Volume:
0.43
시가총액:
$11.51B
수익:
$1.16B
순이익/손실:
$34.55M
주가수익비율:
343.09
EPS:
0.86
순현금흐름:
$134.18M
1주 성능:
-0.82%
1개월 성능:
+12.43%
6개월 성능:
+26.89%
1년 성능:
+41.39%
1일 변동 폭
$289.00
$296.48
1주일 범위
$288.28
$301.15
52주 변동 폭
$148.00
$310.00
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
PEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
294.85 | 11.51B | 1.16B | 34.55M | 134.18M | 0.86 |
|
ABT
Abbott Laboratories
|
132.92 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.43 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.34 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.31 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
LAWSUIT FILED: Penumbra, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP - ACCESS Newswire
SHAREHOLDER ALERT: Penumbra, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm - ACCESS Newswire
Penumbra Inc.: Can Its Innovation & Product Pipeline Foster Long-Term Growth & Competitiveness? - Smartkarma
Penumbra, Inc. Reports First Quarter 2025 Financial Results - Eastern Progress
We Think You Can Look Beyond Penumbra's (NYSE:PEN) Lackluster Earnings - simplywall.st
Penumbra, Inc. to Present at the BofA Securities 2025 Health Car - GuruFocus
Exclusive: Penumbra Management Team Set for Key Presentation at BofA Healthcare Conference - Stock Titan
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference - Longview News-Journal
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
3 Reasons Growth Investors Will Love Penumbra (PEN) - Yahoo Finance
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Ischemic Neurological Interventional Medical Devices Market - openPR.com
Penumbra projects 12%-14% revenue growth for 2025 amid strong thrombectomy performance - MSN
Penumbra, Inc. (NYSE:PEN) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings Beat: Penumbra, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Penumbra EVP Roberts sells shares worth $180,006 By Investing.com - Investing.com Canada
Penumbra Inc. Earnings Call Highlights Strong U.S. Growth - TipRanks
Penumbra EVP Roberts sells shares worth $180,006 - Investing.com
Abstract 160: Utilization of Penumbra MIDWAY 43 Catheter in Complex Neurovascular Interventions: Case Study Analysis - American Heart Association Journals
Stifel raises Penumbra stock price target to $318 - Investing.com Australia
Penumbra Reaches Analyst Target Price - Nasdaq
Penumbra First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst - Benzinga
Penumbra Inc (PEN) Trading 6.02% Higher on Apr 24 - GuruFocus
UBS raises Penumbra stock price target to $330, maintains Buy rating - Investing.com
Stifel raises Penumbra stock price target to $318 By Investing.com - Investing.com South Africa
Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand - Yahoo Finance
UBS Adjusts Price Target on Penumbra to $330 From $320, Maintains Buy Rating - marketscreener.com
Truist Boosts Penumbra (PEN) Price Target Following Strong Q1 Pe - GuruFocus
Truist Boosts Penumbra (PEN) Price Target Following Strong Q1 Performance | PEN Stock News - GuruFocus
BTIG raises Penumbra stock price target to $320 from $305 By Investing.com - Investing.com South Africa
UBS Increases Price Target for Penumbra (PEN) to $330 | PEN Stoc - GuruFocus
Penumbra (PEN) Target Price Raised to $330 by RBC Capital | PEN Stock News - GuruFocus
Penumbra (PEN) Price Target Raised by Stifel Analyst Following S - GuruFocus
Penumbra (PEN) Sees Price Target Increase to $320 by BTIG | PEN Stock News - GuruFocus
Penumbra (PEN) Sees Price Target Increase Following Strong Q1 Pe - GuruFocus
Penumbra (PEN) Sees Price Target Increase Following Strong Q1 Performance | PEN Stock News - GuruFocus
BTIG raises Penumbra stock price target to $320 from $305 - Investing.com
Penumbra revenue increases 16.3% to USD 324.1M in Q1 2025 - Medical Buyer
Earnings call transcript: Penumbra beats Q1 2025 forecasts, stock surges By Investing.com - Investing.com Canada
Penumbra: Q1 Earnings Snapshot - MySA
Penumbra Inc earnings beat by $0.16, revenue topped estimates - Investing.com India
Penumbra Inc (PEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst International ... - Yahoo Finance
Earnings call transcript: Penumbra beats Q1 2025 forecasts, stock surges - Investing.com
Penumbra Inc (PEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst International Challenges - GuruFocus
Decoding Penumbra Inc (PEN): A Strategic SWOT Insight - GuruFocus
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
12.05%
0.02%
자본화:
|
볼륨(24시간):